Principal Financial Group Inc Kodiak Sciences Inc. Transaction History

Principal Financial Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$3.01 - $7.45 $5,944 - $14,713	-1,975 Reduced 12.0%	14,486 $76,000
Q4 2023 Feb 07, 2024	BUY	$1.4 - $3.24 $1,713 - $3,965	1,224 Added 8.03%	16,461 $50,000
Q2 2023 Aug 07, 2023	BUY	$4.3 - $9.48 $10,724 - $23,643	2,494 Added 19.57%	15,237 $105,000
Q1 2023 May 09, 2023	BUY	$4.81 - $8.88 $5,127 - $9,466	1,066 Added 9.13%	12,743 $79,000
Q4 2022 Feb 09, 2023	BUY	$6.52 - $8.05 $76,134 - $93,999	11,677 New	11,677 $83,000
Q1 2022 May 09, 2022	SELL	$7.09 - $89.45 $84,222 - $1.06 Million	-11,879 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$80.85 - $128.49 $436,509 - $693,717	-5,399 Reduced 31.25%	11,879 $1.01 Million
Q3 2021 Nov 09, 2021	BUY	$81.97 - $106.94 $3,196 - $4,170	39 Added 0.23%	17,278 $1.66 Million
Q2 2021 Aug 10, 2021	BUY	$77.2 - $126.54 $6,870 - $11,262	89 Added 0.52%	17,239 $1.6 Million
Q1 2021 May 10, 2021	SELL	$110.45 - $164.47 $25,072 - $37,334	-227 Reduced 1.31%	17,150 $1.95 Million
Q4 2020 Feb 08, 2021	BUY	$60.78 - $154.03 $220,205 - $558,050	3,623 Added 26.34%	17,377 $2.55 Million
Q3 2020 Nov 06, 2020	SELL	$45.05 - $59.27 $27,210 - $35,799	-604 Reduced 4.21%	13,754 $814,000
Q2 2020 Aug 05, 2020	BUY	$42.74 - $66.25 $613,660 - $951,217	14,358 New	14,358 $777,000
Q1 2020 May 12, 2020	SELL	$38.18 - $73.95 $117,976 - $228,505	-3,090 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$13.9 - $76.65 $42,951 - $236,848	3,090 New	3,090 $222,000

109

40.9M

28.4K

21.2K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $194M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.